In part 1 of a 2-part series, neuro-endocrinologist Andrew G. Herzog, MD, CM, discusses the potential pathophysiology of catamenial epilepsy, why research is limited, and how to improve the standard of care.
The link between head injury and dementia risk is not straightforward, but a neurologist and neuropsychologist discuss potential mechanisms and prevention efforts that can help increase awareness and minimize cognitive problems.
In light of Pain Awareness and Arthritis Awareness Month, Lawrence Edwards, MD, discusses the importance of addressing pain in patients with gout and the role of collaboration between clinical specialties during the management of painful gout flares.
Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.
A 14-year-old adolescent with epilepsy presents with increasing episodes of nosebleeds, increased rate of speech, leg pain with little exercise, and irritable mood. Learn how delayed diagnosis of Graves disease affected her treatment.
The use of triptans is contraindicated in patients with migraine and a history of ischemic stroke or coronary artery disease, although there’s no substantial evidence that they directly increase the risk for vascular events.
In research settings, including patients with neurodegenerative diseases presents challenges regarding consent, communication, and ability to participate that must be addressed in order to avoid evidence-biased care.
The American College of Obstetricians and Gynecologists (ACOG) strongly recommends that all eligible individuals, including those who are pregnant, recently pregnant, and lactating, receive a COVID-19 vaccine.
The American Academy of Pediatrics (AAP) released a policy statement and an accompanying clinical report on identifying and addressing the effects of trauma and stress on children, families, and their health care providers.
Patients with depression can live with symptoms for a long period of time before finding an option that works. One possibility for patients who are unable to find relief through pharmacology is transcranial magnetic stimulation. An expert offers his view on this form of treatment.
José-Alain Sahel, MD, Chairman of the Department of Ophthalmology at the University of Pittsburgh, and Hungarian researcher Botond Roska, MD, discuss a breakthrough that restored the sight of a patient with retinitis pigmentosa and light perception only.
With significant racial inequities existing in access to services for youth with autism spectrum disorder, we spoke with an expert about how those in health care can work together to close these gaps and destigmatize disparities.